Overview

The mission of NeuroNexus Technologies (N2T) is to become the leading supplier of implantable microscale probe systems for establishing chemical and electrical interfaces to the nervous system. N2T's proven multichannel microelectrode technologies are at the core of a focused franchise of neural probe systems directed at providing cutting-edge solutions for treating neurological disorders and diseases, as well as pushing the envelope in the neuroscience research and drug discovery markets.

N2T is a University of Michigan spinout company that was formed in 2004 to commercialize neural probe technologies that were developed over nearly two decades of research in the College of Engineering at Michigan. The university research included establishing the Center for Neural Communication Technology with grants from the National Institutes of Health. Over the past 15 years at Michigan, many types of microscale neural probes were developed and distributed to hundreds of neuroscience researchers around the world for use in their experiments. This extensive research and development effort has resulted in a remarkably robust and well-validated platform technology for interfacing with the brain. N2T has licensed this platform technology from the university and is developing it into a focused franchise of neural probe systems for medical and scientific applications. N2T's products are designed to provide microscale electrical and chemical interfaces with the brain that meet demanding application requirements in cost-effective configurations.

N2T is focused on 'making the connection' to the brain.